Kalvista Pharmaceuticals, Inc. (KALV)

Last Year

26-Apr-23 -- 25-Apr-24

Time Period:

$12.70M Net Amount

Buy:	$13.58M	$11.97 - $14.22
Sell:	($881.27K)	$12.02 - $13.03

Company Sentiment

Drugs - Generic

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

4

+1

0

+2

1

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Sep-23 4:29 PM View:	11-Sep-23 Option Sale ($189.05K)	Cha Albert Director		Kalvista Pharmaceuticals, Inc. - KALV	0% --	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:48 PM View:	20-Feb-24 Option Sale ($170.12K)	Yea Christopher Chief Development Officer		Kalvista Pharmaceuticals, Inc. - KALV	104% 35.71K to 72.89K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:51 PM View:	20-Feb-24 Sale (Planned) ($133.45K)	Feener Edward P. Chief Scientific Officer		Kalvista Pharmaceuticals, Inc. - KALV	(3%) 64.35K to 62.16K	0	($520.81K) (62%)	--	$13.00 - $13.03	Show Txns Hide Txns

21-Feb-24 9:41 PM View:	20-Feb-24 Option Sale ($351.29K)	Crockett Thomas Andrew CEO Director		Kalvista Pharmaceuticals, Inc. - KALV	75% 120.93K to 211.2K	0	($360.45K) (25%)	--	$12.02	Show Txns Hide Txns

21-Feb-24 9:44 PM View:	20-Feb-24 Option Sale ($201.77K)	Audhya Paul K. Chief Medical Officer		Kalvista Pharmaceuticals, Inc. - KALV	466% 9.35K to 52.89K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 8:11 PM View:	08-Feb-24 Purchase $437.28K	Venrock Healthcare Capital ... 10% Owner		Kalvista Pharmaceuticals, Inc. - KALV	35% 3.57M to 4.82M	$13.58M 30%	0	$11.97 - $14.22	--	Show Txns Hide Txns

21-Feb-24 9:46 PM View:	20-Feb-24 Option Sale ($321.85K)	Palleiko Ben CHIEF EXECUTIVE OFFICER Director		Kalvista Pharmaceuticals, Inc. - KALV	157% 72.8K to 187.31K	0	0	--	--	Show Txns Hide Txns